These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36262424)

  • 41. Current progress on microRNAs-based therapeutics in neurodegenerative diseases.
    Pereira P; Queiroz JA; Figueiras A; Sousa F
    Wiley Interdiscip Rev RNA; 2017 May; 8(3):. PubMed ID: 27882692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strategies to antagonize miRNA functions in vitro and in vivo.
    Baigude H; Rana TM
    Nanomedicine (Lond); 2014 Nov; 9(16):2545-55. PubMed ID: 25490425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Control of oncogenic miRNA function by light-activated miRNA antagomirs.
    Connelly CM; Deiters A
    Methods Mol Biol; 2014; 1165():99-114. PubMed ID: 24839022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma.
    Yang C; Wang R; Hardy P
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of miRNA-based therapeutic approaches for cancer patients.
    Takahashi RU; Prieto-Vila M; Kohama I; Ochiya T
    Cancer Sci; 2019 Apr; 110(4):1140-1147. PubMed ID: 30729639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrant expression of microRNAs in bladder cancer.
    Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
    Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations.
    Hemida MG; Ye X; Thair S; Yang D
    Mol Diagn Ther; 2010 Oct; 14(5):271-82. PubMed ID: 21053993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of microRNAs in breast cancer stem cells.
    Schwarzenbacher D; Balic M; Pichler M
    Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elucidating miRNA Function in Cancer Biology via the Molecular Genetics' Toolbox.
    Azlan A; Rajasegaran Y; Kang Zi K; Rosli AA; Yik MY; Yusoff NM; Heidenreich O; Moses EJ
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
    Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
    Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs as therapeutic targets in chemoresistance.
    Garofalo M; Croce CM
    Drug Resist Updat; 2013; 16(3-5):47-59. PubMed ID: 23757365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers.
    Masood N; Basharat Z; Khan T; Yasmin A
    Pathol Oncol Res; 2017 Oct; 23(4):707-715. PubMed ID: 28070818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The emerging role of microRNAs in resistance to lung cancer treatments.
    MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.
    Cushing L; Jiang Z; Kuang P; Lü J
    Am J Respir Cell Mol Biol; 2015 Apr; 52(4):397-408. PubMed ID: 25211015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploiting microRNAs As Cancer Therapeutics.
    Robb T; Reid G; Blenkiron C
    Target Oncol; 2017 Apr; 12(2):163-178. PubMed ID: 28138797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.
    Lee TJ; Yuan X; Kerr K; Yoo JY; Kim DH; Kaur B; Eltzschig HK
    Pharmacol Rev; 2020 Jul; 72(3):639-667. PubMed ID: 32554488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The infinite possibilities of RNA therapeutics.
    Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The potential role of miRNAs in multiple myeloma therapy.
    Caracciolo D; Montesano M; Altomare E; Scionti F; Di Martino MT; Tagliaferri P; Tassone P
    Expert Rev Hematol; 2018 Oct; 11(10):793-803. PubMed ID: 30148649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.